Document is current
Any future updates will be listed below
-
Authors
Lalioti, Maria-Eleni
Romero-Mulero, Mari Carmen https://orcid.org/0000-0002-6705-7613
Karabacz, Noémie
Mess, Julian
Demollin, Helen
Rettkowski, Jasmin https://orcid.org/0009-0006-1504-0816
Schuldes, Konrad
Mitterer, Michael
Wadle, Carolin
Shoumariyeh, Khalid
Egg, Mirijam
Alfonso-Gonzalez, Carlos
Jäcklein, Karin
Schönberger, Katharina
Karantzelis, Nikolaos
Reisig, Gregor
Aktories, Philipp
Mayer, Isabella M. https://orcid.org/0000-0002-9164-9547
Tsoukala, Ioanna
Schäffer, Alexander
Tirado-Gonzalez, Irene
Dugourd, Aurélien https://orcid.org/0000-0002-0714-028X
Braun, Lukas M. https://orcid.org/0000-0003-0770-4994
Silva-Rego, Beatriz
Jones, Michael-Jason
Kierdorf, Katrin https://orcid.org/0000-0002-9272-4780
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Reising, Kilian
Walter, Sebastian Gottfried https://orcid.org/0000-0002-6203-8616
Medyouf, Hind
Hilgers, Valérie https://orcid.org/0000-0002-4551-0931
Ghiaur, Gabriel https://orcid.org/0000-0002-3955-7944
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
Karpova, Darja
Renders, Simon
Gravius, Sascha
Buescher, Joerg https://orcid.org/0000-0002-6547-0076
Cabezas-Wallscheid, Nina https://orcid.org/0000-0003-0870-0530
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 5 June 2025
First Online: 15 July 2025
Competing interests
: J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer and Grunenthal. A.D. reports funding from Pfizer. G.G. received research funds from Abbvie Inc., Kinomica Inc., Menarini Richerche Inc. and Arcellx. The other authors declare no competing interests.
